Is Inherent Reasonableness Coming Back to CMS?
CMS is contemplating the use of its authority to adjust payment amounts that are inherently unreasonable as an alternative to using the competitive bidding process for non-mail order testing supplies at this time. The agency believes that this will help reduce the difference in price between mail order and non-mail order diabetic testing supplies, and create program savings. In addition, it believes using its inherently unreasonable authority will allow beneficiaries greater choice of supplier than use of the competitive bidding process.
CMS will host a public meeting Monday, July 23, 2012 from 9 am to 1 pm to solicit comments from suppliers and other interested parties. Both oral and written comments will be accepted. Participants must register in advance.
As reported here, earlier this month the U.S. Drug Enforcement Administration (DEA) issued a decision declining to transfer marijuana out of Schedule I. As marijuana remains a Schedule I...07 September 2016